Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002187731 | SCV002342396 | likely benign | not provided | 2024-08-23 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV003224609 | SCV003920560 | uncertain significance | Atypical hemolytic-uremic syndrome with thrombomodulin anomaly; Thrombomodulin-related bleeding disorder | 2022-06-03 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.09% (40/41426) (https://gnomad.broadinstitute.org/variant/20-23048144-A-G?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:1553770). This variant amino acid Alanine (Ala) is present in several species including multiple mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003958533 | SCV004773704 | likely benign | THBD-related disorder | 2023-09-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |